Kevin Leach
Corporate Officer/Principal bei Massachusetts Institute of Technology
Profil
Kevin Leach currently works at Massachusetts Institute of Technology, as Member.
Dr. Leach also formerly worked at Travere Therapeutics, Inc., as Senior Director-Translational Research and F-Star Therapeutics, Inc. (United States), as VP-Nonclinical & Translational Research.
Dr. Leach received his undergraduate degree from the University of Richmond.
Aktive Positionen von Kevin Leach
| Unternehmen | Position | Beginn |
|---|---|---|
| Massachusetts Institute of Technology | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Kevin Leach
| Unternehmen | Position | Ende |
|---|---|---|
| TRAVERE THERAPEUTICS, INC. | Corporate Officer/Principal | - |
| SPRING BANK PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Ausbildung von Kevin Leach
| University of Richmond | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TRAVERE THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
F-Star Therapeutics, Inc. (United States)
 F-Star Therapeutics, Inc. (United States) Pharmaceuticals: MajorHealth Technology F-Star Therapeutics, Inc. engages in discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid (SMNH) chemistry platform. Its products are used for the treatment of viral infections, inflammatory diseases, and certain cancers. The company was founded by Douglas J. Jensen and Radhakrishnan P. Iyer on October 7, 2002 and is headquartered in Hopkinton, MA. | Health Technology |
